Search the Newsreel

Coca-Cola's 64-Year Dividend Streak: Why Berkshire's $1.3 Billion Bet Now Yields 65% Annually

Coca-Cola's impressive 64-year dividend growth streak has made it a cornerstone of Berkshire Hathaway's portfolio. Warren Buffett's initial $1.3 billion investment in Coca-Cola now generates $848 million in annual dividend income, representing a 65% yield on the original cost. Despite some of Berkshire's consumer …

Columbia Banking System Announces $0.37 Per Common Share Dividend

Columbia Banking System, Inc. announced that its Board of Directors has approved a quarterly cash dividend of $0.37 per common share. The dividend will be payable on September 14, 2026, to shareholders of record as of August 28, 2026. Columbia Banking System is the …

Lincoln Pharma Q1 Results FY27: PAT Rs 36 Cr, Revenue Rs 177 crore

Columbia Banking System, Inc. $COLB Holdings Lifted by Bank of America Corp DE

The Coca-Cola Company: Konsensus der Analysten und Kursziel | 850663 | US1912161007

Columbia Bank Opens First Branch Location in Colorado Springs

Columbia Bank has opened its first commercial office and retail branch in Colorado Springs' Downtown Trolley District, marking a physical expansion after operating in the area since 2023 without a branch. This move signifies the bank's long-term commitment to the region, providing full-service retail …

Colgate® Launches New Optic White™ Vitamin C with j-hope of BTS

Colgate-Palmolive has launched a new whitening toothpaste, Colgate Optic White Vitamin C, featuring 95% pure stabilized Vitamin C. The company announced a major Asia Pacific partnership with j-hope of BTS, known for his "Sunshine Smile," as the official ambassador. The product claims to remove …

CG Oncology's bladder cancer drug shows strong results with 75% response rate and no severe side effects.

CG Oncology's experimental drug cretositimogene grenadenorepvec (cret) has shown promising results in treating non-muscle invasive bladder cancer (NMIBC), achieving a 75% complete response rate and demonstrating a best-in-class safety profile with no severe adverse events. The company plans to submit a Biologics License Application …

Grove (GROV) Q2 2026 Earnings Call Transcript

CG Oncology Stock: Circling Back After Huge Rally (NASDAQ:CGON)

News / Colonial profit climbs to $18.7m

Pyxis Oncology (NASDAQ:PYXS) Releases Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Pyxis Oncology (NASDAQ:PYXS) reported a quarterly loss of $0.40 per share, missing analysts' consensus estimates by $0.06. The stock traded down to $3.01 with a market capitalization of $190.68 million, but analyst sentiment remains a "Moderate Buy" with a $7.50 target price. Institutional investors …

Kura Oncology (KURA) Stock Revenue Growth Clashes With Mounting Losses

Coca-Cola’s Raised Guidance And Margin Gains Might Change The Case For Investing In Coca-Cola (KO)

Coca-Cola recently posted a strong second quarter, with healthy global demand, improving margins, broad-based volume growth, and management raising full-year revenue and earnings guidance. This upgraded outlook, alongside ongoing market-share gains and disciplined cost control, has reinforced investor confidence in the company's ability to …

CCEP Downgraded by UBS -- Price Target Lowered to $107.00

UBS analyst Sanjeet Auija downgraded Coca-Cola Europacific Partners PLC (CCEP) from Buy to Neutral, lowering the price target to $107.00 from $109.00 due to a cautious outlook. Despite a strong GF Score of 85/100, CCEP is considered 5.9% overvalued by GuruFocus, though its P/E …

Colonial Motor lifts profit and dividend as it pivots harder into EVs

Washington Mutual Investors Fund, AWSHX, Refuses to Buy Certain Stocks. That’s the Point

Quick Read AWSHX bars tobacco, alcohol, and gambling companies from its portfolio yet delivered a 17% one-year return and 239% gain over ten years. KO and JPM exemplify qualifying holdings, with Coca-Cola's quarterly dividend tripling since 1999 and JPMorgan trading near 15 times earnings. …

CGON (CGON) investor lists 25,989-share sale after series of stock disposals

An investor in CG Oncology, Inc. (CGON) has filed a Form 144, indicating a planned sale of 25,989 common shares with an aggregate market value of $1,973,970.86, expected on August 13, 2026. This filing also discloses a series of prior open-market sales by Ambaw …

Aktis Oncology (NASDAQ:AKTS) Posts Earnings Results, Meets Expectations

Aktis Oncology (NASDAQ:AKTS) recently reported its earnings, meeting the consensus estimate for EPS at ($0.44) and surpassing revenue expectations with $3.38 million. Despite the positive earnings surprise, the stock traded down 0.9% to $23.79, giving the company a market capitalization of approximately $1.27 billion. …

CARDIFF ONCOLOGY, INC. : WILLIAM BLAIR CUTS TO MARKET PERFORM RATING

William Blair has downgraded its rating for Cardiff Oncology, Inc. to Market Perform. This article from Reuters, republished by Webull, indicates a change in analyst sentiment towards the company. Further details on the reasons for the downgrade would require logging in to the Webull …

Collegium Pharmaceutical to repurchase $50 million in stock

Collegium Pharmaceutical announced an Accelerated Share Repurchase agreement with Jefferies LLC to buy back $50 million of its common stock. This action is part of a larger $150 million share repurchase program authorized in July 2025, leaving $100 million remaining after this transaction. The …

Wellington Group (COLB) discloses 11.7M-share, 4.13% stake in Columbia Banking

Wellington Management Group LLP and related entities have filed an amended Schedule 13G, revealing a beneficial ownership of 11,686,430 shares, or 4.13%, in Columbia Banking System, Inc. They report shared voting power over 10,208,638 shares and shared dispositive power over all 11,686,430 shares. The …

CG Oncology (CGON): Wellington group discloses 5.3M-share, 6.04% ownership position

A group of affiliated Wellington entities has disclosed a beneficial ownership of 5,324,751 shares of CG Oncology (CGON) common stock, representing 6.04% of the class. This disclosure, filed via a SCHEDULE 13G/A, indicates shared voting power over 4,637,354 shares and shared dispositive power over …

Lincoln Electric Holdings (LECO) Faces Americas Welding Change, Is The Stock Still Cheap?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Leadership change in Americas Welding Lincoln Electric Holdings (LECO) has been put in focus after Michael J. Whitehead, Executive Vice President and President …

Colombier Acquisition Corp. III (CLBR) earns $2.8M on $302M SPAC trust in H1 2026

Aktis Oncology (AKTS) builds cash to $517M as losses rise with clinical spend

Aktis Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Colombier Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Nicola Mining Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Aktis Oncology (AKTS) posts Q2 2026 results with $517M cash runway into 2029

Aktis Oncology reported its Q2 2026 results, highlighting progress in its targeted radiopharmaceutical pipeline with promising early data for AKY-2519 and ongoing trials for AKY-1189. The company maintains a strong financial position with $517.3 million in cash, cash equivalents, and marketable securities, projected to …

Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026

Aktis Oncology reported its financial results and business highlights for the second quarter of 2026, showcasing strong execution and progress in its clinical pipeline. The company presented promising first-in-human clinical imaging and dosimetry data for AKY-2519 and is actively enrolling patients in Phase 1b …

Nicola Mining (NICM) raises capital, ramps mill revenue and records H1 2026 loss

Nicola Mining Inc. reported a significant increase in milling revenue for the first half of 2026, reaching $2,594,863 compared to $79,240 in the previous year. Despite this, the company posted a net loss of $4,004,563, primarily due to lower fair value gains on marketable …

Hill's Pet Nutrition hires new HR chief from Colgate-Palmolive

Wendy Boise has been appointed as the new executive vice president of people for Hill's Pet Nutrition, based in the Kansas City area. She will be responsible for leading the integration of new technology and AI within the company's HR functions. Boise comes to …

Columbia Financial stock hits all-time high at 11.75 USD By Investing.com

Columbia Financial Inc.'s stock has reached an all-time high of $11.75, representing a 73.83% increase over the past year. Despite this, InvestingPro data suggests the stock may be overvalued with a P/E ratio of 45.1 and its RSI indicating it is in overbought territory. …

Columbia Financial (CLBK) SEVP details stock and option holdings in Form 3

Lewis Oliver Edward Jr, SEVP & Head Commercial Banking at Columbia Financial (CLBK), has filed a Form 3 detailing his equity holdings in the company. The filing reports direct and indirect ownership of common stock through various plans, as well as multiple tranches of …

Columbia Financial (CLBK) director Kuiken reports direct and indirect stock holdings

Columbia Financial, Inc. director James Michael Kuiken has filed a Form 3, disclosing his initial beneficial ownership in the company. The report indicates he directly holds 35,356 shares of Common Stock and indirectly holds 6,494 shares through a Stock Award V, as of July …